Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 133 to 144 of 144 entries
Sorted by: Best Match Show Resources per page
Highlighting: a mechanism relevant for word learning.

Frontiers in psychology

Yoshida H, Burling JM.
PMID: 22912620
Front Psychol. 2012 Aug 14;3:262. doi: 10.3389/fpsyg.2012.00262. eCollection 2012.

What we attend to at any moment determines what we learn at that moment, and this also depends on our past learning. This focused conceptual paper concentrates on a single well-documented attention mechanism - highlighting. This phenomenon - well...

Cite
Yoshida H, Burling JM. Highlighting: a mechanism relevant for word learning. Front Psychol. 2012;3:262doi: 10.3389/fpsyg.2012.00262.
Yoshida, H., & Burling, J. M. (2012). Highlighting: a mechanism relevant for word learning. Frontiers in psychology, 3262. https://doi.org/10.3389/fpsyg.2012.00262
Yoshida, Hanako, and Burling, Joseph Michael. "Highlighting: a mechanism relevant for word learning." Frontiers in psychology vol. 3 (2012): 262. doi: https://doi.org/10.3389/fpsyg.2012.00262
Yoshida H, Burling JM. Highlighting: a mechanism relevant for word learning. Front Psychol. 2012 Aug 14;3:262. doi: 10.3389/fpsyg.2012.00262. eCollection 2012. PMID: 22912620; PMCID: PMC3418634.
Copy Download .nbib Format: NLM
Mixed spine metastasis detection through positron emission tomography/computed tomography synthesis and multiclassifier.

Journal of medical imaging (Bellingham, Wash.)

Yao J, Burns JE, Sanoria V, Summers RM.
PMID: 28612036
J Med Imaging (Bellingham). 2017 Apr;4(2):024504. doi: 10.1117/1.JMI.4.2.024504. Epub 2017 Jun 05.

Bone metastases are a frequent occurrence with cancer, and early detection can guide the patient's treatment regimen. Metastatic bone disease can present in density extremes as sclerotic (high density) and lytic (low density) or in a continuum with an...

Cite
Yao J, Burns JE, Sanoria V, et al. Mixed spine metastasis detection through positron emission tomography/computed tomography synthesis and multiclassifier. J Med Imaging (Bellingham). 2017;4(2):024504doi: 10.1117/1.JMI.4.2.024504.
Yao, J., Burns, J. E., Sanoria, V., & Summers, R. M. (2017). Mixed spine metastasis detection through positron emission tomography/computed tomography synthesis and multiclassifier. Journal of medical imaging (Bellingham, Wash.), 4(2), 024504. https://doi.org/10.1117/1.JMI.4.2.024504
Yao, Jianhua, et al. "Mixed spine metastasis detection through positron emission tomography/computed tomography synthesis and multiclassifier." Journal of medical imaging (Bellingham, Wash.) vol. 4,2 (2017): 024504. doi: https://doi.org/10.1117/1.JMI.4.2.024504
Yao J, Burns JE, Sanoria V, Summers RM. Mixed spine metastasis detection through positron emission tomography/computed tomography synthesis and multiclassifier. J Med Imaging (Bellingham). 2017 Apr;4(2):024504. doi: 10.1117/1.JMI.4.2.024504. Epub 2017 Jun 05. PMID: 28612036; PMCID: PMC5460314.
Copy Download .nbib Format: NLM
Impact of Subclinical Hypothyroidism on Cardiometabolic Biomarkers in Women.

Journal of the Endocrine Society

Harada PHN, Buring JE, Cook NR, Cobble ME, Kulkarni KR, Mora S.
PMID: 28580441
J Endocr Soc. 2017 Feb 01;1(2):113-123. doi: 10.1210/js.2016-1085. Epub 2017 Jan 13.

CONTEXT: Whether subclinical hypothyroidism (SCH) is associated with cardiometabolic abnormalities is uncertain.OBJECTIVE: To examine diverse cardiometabolic biomarkers across euthyroid, SCH, and overt hypothyroidism (HT) in women free of cardiovascular disease (CVD).DESIGN: Cross-sectional adjusted associations for lipids, lipoprotein subclasses, lipoprotein...

Cite
Harada PHN, Buring JE, Cook NR, et al. Impact of Subclinical Hypothyroidism on Cardiometabolic Biomarkers in Women. J Endocr Soc. 2017;1(2):113-123doi: 10.1210/js.2016-1085.
Harada, P. H. N., Buring, J. E., Cook, N. R., Cobble, M. E., Kulkarni, K. R., & Mora, S. (2017). Impact of Subclinical Hypothyroidism on Cardiometabolic Biomarkers in Women. Journal of the Endocrine Society, 1(2), 113-123. https://doi.org/10.1210/js.2016-1085
Harada, Paulo H N, et al. "Impact of Subclinical Hypothyroidism on Cardiometabolic Biomarkers in Women." Journal of the Endocrine Society vol. 1,2 (2017): 113-123. doi: https://doi.org/10.1210/js.2016-1085
Harada PHN, Buring JE, Cook NR, Cobble ME, Kulkarni KR, Mora S. Impact of Subclinical Hypothyroidism on Cardiometabolic Biomarkers in Women. J Endocr Soc. 2017 Feb 01;1(2):113-123. doi: 10.1210/js.2016-1085. Epub 2017 Jan 13. PMID: 28580441; PMCID: PMC5453652.
Copy Download .nbib Format: NLM
Sleep Quality After Modified Uvulopalatopharyngoplasty: Results From the SKUP3 Randomized Controlled Trial.

Sleep

Sundman J, Friberg D, Bring J, Lowden A, Nagai R, Browaldh N.
PMID: 30257002
Sleep. 2018 Nov 01;41(11). doi: 10.1093/sleep/zsy173.

No abstract available.

Cite
Sundman J, Friberg D, Bring J, et al. Sleep Quality After Modified Uvulopalatopharyngoplasty: Results From the SKUP3 Randomized Controlled Trial. Sleep. 2018;41(11)doi: 10.1093/sleep/zsy173.
Sundman, J., Friberg, D., Bring, J., Lowden, A., Nagai, R., & Browaldh, N. (2018). Sleep Quality After Modified Uvulopalatopharyngoplasty: Results From the SKUP3 Randomized Controlled Trial. Sleep, 41(11), . https://doi.org/10.1093/sleep/zsy173
Sundman, Joar, et al. "Sleep Quality After Modified Uvulopalatopharyngoplasty: Results From the SKUP3 Randomized Controlled Trial." Sleep vol. 41,11 (2018). doi: https://doi.org/10.1093/sleep/zsy173
Sundman J, Friberg D, Bring J, Lowden A, Nagai R, Browaldh N. Sleep Quality After Modified Uvulopalatopharyngoplasty: Results From the SKUP3 Randomized Controlled Trial. Sleep. 2018 Nov 01;41(11). doi: 10.1093/sleep/zsy173. PMID: 30257002.
Copy Download .nbib Format: NLM
Temporary inactivation of the anterior part of the bed nucleus of the stria terminalis blocks alarm pheromone-induced defensive behavior in rats.

Frontiers in neuroscience

Breitfeld T, Bruning JE, Inagaki H, Takeuchi Y, Kiyokawa Y, Fendt M.
PMID: 26441496
Front Neurosci. 2015 Sep 09;9:321. doi: 10.3389/fnins.2015.00321. eCollection 2015.

Rats emit an alarm pheromone in threatening situations. Exposure of rats to this alarm pheromone induces defensive behaviors, such as head out behavior, and increases c-Fos expression in brain areas involved in the mediation of defensive behaviors. One of...

Cite
Breitfeld T, Bruning JE, Inagaki H, et al. Temporary inactivation of the anterior part of the bed nucleus of the stria terminalis blocks alarm pheromone-induced defensive behavior in rats. Front Neurosci. 2015;9:321doi: 10.3389/fnins.2015.00321.
Breitfeld, T., Bruning, J. E., Inagaki, H., Takeuchi, Y., Kiyokawa, Y., & Fendt, M. (2015). Temporary inactivation of the anterior part of the bed nucleus of the stria terminalis blocks alarm pheromone-induced defensive behavior in rats. Frontiers in neuroscience, 9321. https://doi.org/10.3389/fnins.2015.00321
Breitfeld, Tino, et al. "Temporary inactivation of the anterior part of the bed nucleus of the stria terminalis blocks alarm pheromone-induced defensive behavior in rats." Frontiers in neuroscience vol. 9 (2015): 321. doi: https://doi.org/10.3389/fnins.2015.00321
Breitfeld T, Bruning JE, Inagaki H, Takeuchi Y, Kiyokawa Y, Fendt M. Temporary inactivation of the anterior part of the bed nucleus of the stria terminalis blocks alarm pheromone-induced defensive behavior in rats. Front Neurosci. 2015 Sep 09;9:321. doi: 10.3389/fnins.2015.00321. eCollection 2015. PMID: 26441496; PMCID: PMC4563084.
Copy Download .nbib Format: NLM
Restoring effective sleep tranquility (REST): A feasibility and pilot study.

The British journal of occupational therapy

Eakman AM, Schmid AA, Henry KL, Rolle NR, Schelly C, Pott CE, Burns JE.
PMID: 28626295
Br J Occup Ther. 2017 Jun;80(6):350-360. doi: 10.1177/0308022617691538. Epub 2017 Apr 05.

INTRODUCTION: The purpose of this pilot study was to establish the feasibility of completing a future controlled trial of a multi-component cognitive behavioral therapy for insomnia program for military veterans with sleep disturbance.METHOD: This was a single-arm feasibility and...

Cite
Eakman AM, Schmid AA, Henry KL, et al. Restoring effective sleep tranquility (REST): A feasibility and pilot study. Br J Occup Ther. 2017;80(6):350-360doi: 10.1177/0308022617691538.
Eakman, A. M., Schmid, A. A., Henry, K. L., Rolle, N. R., Schelly, C., Pott, C. E., & Burns, J. E. (2017). Restoring effective sleep tranquility (REST): A feasibility and pilot study. The British journal of occupational therapy, 80(6), 350-360. https://doi.org/10.1177/0308022617691538
Eakman, Aaron M, et al. "Restoring effective sleep tranquility (REST): A feasibility and pilot study." The British journal of occupational therapy vol. 80,6 (2017): 350-360. doi: https://doi.org/10.1177/0308022617691538
Eakman AM, Schmid AA, Henry KL, Rolle NR, Schelly C, Pott CE, Burns JE. Restoring effective sleep tranquility (REST): A feasibility and pilot study. Br J Occup Ther. 2017 Jun;80(6):350-360. doi: 10.1177/0308022617691538. Epub 2017 Apr 05. PMID: 28626295; PMCID: PMC5458872.
Copy Download .nbib Format: NLM
Effect of Vitamin D Supplementation on Urinary Incontinence in Older Women: Ancillary Findings from a Randomized Trial.

American journal of obstetrics and gynecology

Markland AD, Vaughan C, Huang A, Kim E, Bubes VY, Tangpricha V, Buring J, Lee IM, Cook N, Manson JE, Grodstein F.
PMID: 34678177
Am J Obstet Gynecol. 2021 Oct 19; doi: 10.1016/j.ajog.2021.10.017. Epub 2021 Oct 19.

BACKGROUND: Observational studies among older women have associated vitamin D insufficiency with greater prevalence and incidence of urinary incontinence than older women with adequate vitamin D status. Less is known about the effect of vitamin D supplementation on reducing...

Cite
Markland AD, Vaughan C, Huang A, et al. Effect of Vitamin D Supplementation on Urinary Incontinence in Older Women: Ancillary Findings from a Randomized Trial. Am J Obstet Gynecol. 2021;doi: 10.1016/j.ajog.2021.10.017.
Markland, A. D., Vaughan, C., Huang, A., Kim, E., Bubes, V. Y., Tangpricha, V., Buring, J., Lee, I. M., Cook, N., Manson, J. E., & Grodstein, F. (2021). Effect of Vitamin D Supplementation on Urinary Incontinence in Older Women: Ancillary Findings from a Randomized Trial. American journal of obstetrics and gynecology, . https://doi.org/10.1016/j.ajog.2021.10.017
Markland, Alayne D, et al. "Effect of Vitamin D Supplementation on Urinary Incontinence in Older Women: Ancillary Findings from a Randomized Trial." American journal of obstetrics and gynecology vol. (2021). doi: https://doi.org/10.1016/j.ajog.2021.10.017
Markland AD, Vaughan C, Huang A, Kim E, Bubes VY, Tangpricha V, Buring J, Lee IM, Cook N, Manson JE, Grodstein F. Effect of Vitamin D Supplementation on Urinary Incontinence in Older Women: Ancillary Findings from a Randomized Trial. Am J Obstet Gynecol. 2021 Oct 19; doi: 10.1016/j.ajog.2021.10.017. Epub 2021 Oct 19. PMID: 34678177.
Copy Download .nbib Format: NLM
Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study.

Journal of clinical lipidology

Imran TF, Kim E, Buring JE, Lee IM, Gaziano JM, Djousse L.
PMID: 33500188
J Clin Lipidol. 2021 Mar-Apr;15(2):266-274. doi: 10.1016/j.jacl.2021.01.001. Epub 2021 Jan 07.

BACKGROUND: The link between nut consumption and cardiovascular (CV) mortality remains unclear.OBJECTIVE: to examine whether nut consumption is associated with CV mortality and estimate the proportion of reduced risk of CV mortality explained by intermediate factors.METHODS: We studied 39,167...

Cite
Imran TF, Kim E, Buring JE, et al. Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study. J Clin Lipidol. 2021;15(2):266-274doi: 10.1016/j.jacl.2021.01.001.
Imran, T. F., Kim, E., Buring, J. E., Lee, I. M., Gaziano, J. M., & Djousse, L. (2021). Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study. Journal of clinical lipidology, 15(2), 266-274. https://doi.org/10.1016/j.jacl.2021.01.001
Imran, Tasnim F, et al. "Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study." Journal of clinical lipidology vol. 15,2 (2021): 266-274. doi: https://doi.org/10.1016/j.jacl.2021.01.001
Imran TF, Kim E, Buring JE, Lee IM, Gaziano JM, Djousse L. Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study. J Clin Lipidol. 2021 Mar-Apr;15(2):266-274. doi: 10.1016/j.jacl.2021.01.001. Epub 2021 Jan 07. PMID: 33500188; PMCID: PMC8666004.
Copy Download .nbib Format: NLM
From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor.

Journal of medicinal chemistry

Turner LD, Trinh CH, Hubball RA, Orritt KM, Lin CC, Burns JE, Knowles MA, Fishwick CWG.
PMID: 34780700
J Med Chem. 2021 Nov 15; doi: 10.1021/acs.jmedchem.1c01163. Epub 2021 Nov 15.

Fibroblast growth factor receptors (FGFRs) are implicated in a range of cancers with several pan-kinase and selective-FGFR inhibitors currently being evaluated in clinical trials. Pan-FGFR inhibitors often cause toxic side effects and few examples of subtype-selective inhibitors exist. Herein,...

Cite
Turner LD, Trinh CH, Hubball RA, et al. From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor. J Med Chem. 2021;doi: 10.1021/acs.jmedchem.1c01163.
Turner, L. D., Trinh, C. H., Hubball, R. A., Orritt, K. M., Lin, C. C., Burns, J. E., Knowles, M. A., & Fishwick, C. W. G. (2021). From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor. Journal of medicinal chemistry, . https://doi.org/10.1021/acs.jmedchem.1c01163
Turner, Lewis D, et al. "From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor." Journal of medicinal chemistry vol. (2021). doi: https://doi.org/10.1021/acs.jmedchem.1c01163
Turner LD, Trinh CH, Hubball RA, Orritt KM, Lin CC, Burns JE, Knowles MA, Fishwick CWG. From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor. J Med Chem. 2021 Nov 15; doi: 10.1021/acs.jmedchem.1c01163. Epub 2021 Nov 15. PMID: 34780700.
Copy Download .nbib Format: NLM
Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study.

Journal of clinical lipidology

Imran TF, Kim E, Buring JE, Lee IM, Gaziano JM, Djousse L.
PMID: 33500188
J Clin Lipidol. 2021 Mar-Apr;15(2):266-274. doi: 10.1016/j.jacl.2021.01.001. Epub 2021 Jan 07.

BACKGROUND: The link between nut consumption and cardiovascular (CV) mortality remains unclear.OBJECTIVE: to examine whether nut consumption is associated with CV mortality and estimate the proportion of reduced risk of CV mortality explained by intermediate factors.METHODS: We studied 39,167...

Cite
Imran TF, Kim E, Buring JE, et al. Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study. J Clin Lipidol. 2021;15(2):266-274doi: 10.1016/j.jacl.2021.01.001.
Imran, T. F., Kim, E., Buring, J. E., Lee, I. M., Gaziano, J. M., & Djousse, L. (2021). Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study. Journal of clinical lipidology, 15(2), 266-274. https://doi.org/10.1016/j.jacl.2021.01.001
Imran, Tasnim F, et al. "Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study." Journal of clinical lipidology vol. 15,2 (2021): 266-274. doi: https://doi.org/10.1016/j.jacl.2021.01.001
Imran TF, Kim E, Buring JE, Lee IM, Gaziano JM, Djousse L. Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study. J Clin Lipidol. 2021 Mar-Apr;15(2):266-274. doi: 10.1016/j.jacl.2021.01.001. Epub 2021 Jan 07. PMID: 33500188; PMCID: PMC8666004.
Copy Download .nbib Format: NLM
Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.

JAMA

Okereke OI, Vyas CM, Mischoulon D, Chang G, Cook NR, Weinberg A, Bubes V, Copeland T, Friedenberg G, Lee IM, Buring JE, Reynolds CF, Manson JE.
PMID: 34932079
JAMA. 2021 Dec 21;326(23):2385-2394. doi: 10.1001/jama.2021.21187.

IMPORTANCE: Marine omega-3 fatty acid (omega-3) supplements have been used to treat depression but their ability to prevent depression in the general adult population is unknown.OBJECTIVE: To test effects of omega-3 supplementation on late-life depression risk and mood scores.DESIGN,...

Cite
Okereke OI, Vyas CM, Mischoulon D, et al. Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial. JAMA. 2021;326(23):2385-2394doi: 10.1001/jama.2021.21187.
Okereke, O. I., Vyas, C. M., Mischoulon, D., Chang, G., Cook, N. R., Weinberg, A., Bubes, V., Copeland, T., Friedenberg, G., Lee, I. M., Buring, J. E., Reynolds, C. F., & Manson, J. E. (2021). Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial. JAMA, 326(23), 2385-2394. https://doi.org/10.1001/jama.2021.21187
Okereke, Olivia I, et al. "Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial." JAMA vol. 326,23 (2021): 2385-2394. doi: https://doi.org/10.1001/jama.2021.21187
Okereke OI, Vyas CM, Mischoulon D, Chang G, Cook NR, Weinberg A, Bubes V, Copeland T, Friedenberg G, Lee IM, Buring JE, Reynolds CF, Manson JE. Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial. JAMA. 2021 Dec 21;326(23):2385-2394. doi: 10.1001/jama.2021.21187. PMID: 34932079; PMCID: PMC8693224.
Copy Download .nbib Format: NLM
Progression of gastrointestinal symptoms over time in patients with systemic sclerosis.

Rheumatology international

Bering J, Griffing WL, Crowell M, Umar SB.
PMID: 33630144
Rheumatol Int. 2021 Jul;41(7):1281-1287. doi: 10.1007/s00296-021-04806-6. Epub 2021 Feb 25.

Up to 90% of patients with systemic sclerosis (SSc) develop gastrointestinal (GI) symptoms. To evaluate whether GI symptoms and quality of life in patients with SSc demonstrate longitudinal stability. Consecutive patients with SSc (n = 100) completed the validated...

Cite
Bering J, Griffing WL, Crowell M, et al. Progression of gastrointestinal symptoms over time in patients with systemic sclerosis. Rheumatol Int. 2021;41(7):1281-1287doi: 10.1007/s00296-021-04806-6.
Bering, J., Griffing, W. L., Crowell, M., & Umar, S. B. (2021). Progression of gastrointestinal symptoms over time in patients with systemic sclerosis. Rheumatology international, 41(7), 1281-1287. https://doi.org/10.1007/s00296-021-04806-6
Bering, Jamie, et al. "Progression of gastrointestinal symptoms over time in patients with systemic sclerosis." Rheumatology international vol. 41,7 (2021): 1281-1287. doi: https://doi.org/10.1007/s00296-021-04806-6
Bering J, Griffing WL, Crowell M, Umar SB. Progression of gastrointestinal symptoms over time in patients with systemic sclerosis. Rheumatol Int. 2021 Jul;41(7):1281-1287. doi: 10.1007/s00296-021-04806-6. Epub 2021 Feb 25. PMID: 33630144.
Copy Download .nbib Format: NLM
Showing 133 to 144 of 144 entries